Psychiatric illness Archives

Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

Bipolar I Disorder, Clinical Trials, Forecasts, Mental Illness, Presentations, Psychiatric illness, R&D, Schizophrenia, Schizophrenia, Schizophrenia, Schizophrenia, Therapeutics

Alkermes plc today presented new research from its psychiatry portfolio at the 2022 Congress of the Schizophrenia International Research Society (SIRS).

Cosette Pharmaceuticals Launches First Injectable Product – Prochlorperazine Edisylate Injection in the U.S.

Brand Launches, Business, Daiichi Sankyo, Injectables, IQVIA, Issue Archives, Nausea and Vomiting, Pharma Companies, R&D, Schizophrenia, Therapeutics

Cosette Pharmaceuticals Inc., a New Jersey-based pharmaceutical company, announced the launch of Prochlorperazine Edisylate injection, 10 mg/2ml (5mg/ml).

Specific Gene Mutation Linked to Schizophrenia

Brain, Columbia University, Genes, Medical Journals, Neuron, Psychiatric illness, R&D, Researchers, Schizophrenia, SETD1A Gene

Researchers with NYC’s Columbia University published research showing how one of the genes that has definitely been tied to schizophrenia, SETD1A, works to increase risk of the disease.